Belimumab: First targeted biological treatment for systemic lupus erythematosus

Belimumab: First targeted biological treatment for systemic lupus erythematosus

Bibliographic Details
Main Authors:	Dubey, Ashok K., Handu, Shailendra S., Dubey, Suparna, Sharma, Prashant, Sharma, K. K., Ahmed, Qazi M.
Format:	Online
Language:	English
Published:	Medknow Publications Pvt Ltd 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198539/

Similar Items

Belimumab in Systemic Lupus Erythematosus
by: Srivastava, Ankita
Published: (2016)

Belimumab in systemic lupus erythematosus
by: Vilas-Boas, Andreia, et al.
Published: (2015)

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
by: van Vollenhoven, Ronald F, et al.
Published: (2012)

Are we pharmacovigilant enough in ophthalmic practice?
by: Dubey, Ashok, et al.
Published: (2013)

Suvorexant: The first orexin receptor antagonist to treat insomnia
by: Dubey, Ashok K., et al.
Published: (2015)

New treatment options for lupus – a focus on belimumab
by: Chiche, Laurent, et al.
Published: (2012)

Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis
by: Pierotti, Francesca, et al.
Published: (2015)

Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
by: Specchia, Maria Lucia, et al.
Published: (2014)

Effect of Musa sapientum Stem Extract on Animal Models of Depression
by: Reddy, Aditya J., et al.
Published: (2016)

Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis
by: Kandala, Ngianga-Bakwin, et al.
Published: (2013)

Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus
by: Sheikh, Saira Z., et al.
Published: (2016)

Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus
by: Schwarting, A, et al.
Published: (2016)

Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program
by: Yapa, S Wickramaratne Senarath, et al.
Published: (2016)

Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab
by: Roth, D A, et al.
Published: (2015)

A Rare Case of Prototheca Algaemia in a Patient with Systemic Lupus Erythematosus and Recent Belimumab Infusion
by: Mejia-Otero, Carolina, et al.
Published: (2012)

Safety, tolerability, pharmacokinetics and pharmacodynamics of belimumab in Japanese patients with mild-to-moderate systemic lupus erythematosus
by: Yamada, Masanori, et al.
Published: (2013)

Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis
by: Frieri, Marianne, et al.
Published: (2015)

Development of targeted biologics for systemic lupus erythematosus
by: Lipsky, Peter E
Published: (2012)

First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study
by: Schwarting, Andreas, et al.
Published: (2016)

Real life experience on the effect of Belimumab in patients with active systemic lupus
by: Scheinberg, Morton, et al.
Published: (2014)

Treatment targets in systemic lupus erythematosus: biology and clinical perspective
by: Marian, Valentin, et al.
Published: (2012)

Bullous Systemic Lupus Erythematosus
by: Grover, Chander, et al.
Published: (2013)

Biological Therapy in Systemic Lupus Erythematosus
by: Postal, Mariana, et al.
Published: (2012)

Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
by: van Vollenhoven, Ronald F., et al.
Published: (2016)

Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA
by: Collins, C E, et al.
Published: (2016)

To target or not to target APRIL in systemic lupus erythematosus: that is the question!
by: Morel, Jacques, et al.
Published: (2013)

Chorea as the First and Only Manifestation of Systemic Lupus Erythematosus
by: Poil, Abdul Razzakh, et al.
Published: (2012)

Panniculitis as the first sign of systemic lupus erythematosus
by: Sanavi, Suzan, et al.
Published: (2011)

Treatment of Bullous Systemic Lupus Erythematosus
by: Duan, Lihua, et al.
Published: (2015)

Lupus Erythematosus Panniculitis in Pregnancy
by: Gondane, Swati, et al.
Published: (2015)

Lupus cystitis: An unusual presentation of systemic lupus erythematosus
by: Mukhopadhyay, S., et al.
Published: (2014)

Melanocortin Peptides: Potential Targets in Systemic Lupus Erythematosus
by: Loram, Lisa Carole, et al.
Published: (2014)

Neonatal Lupus Erythematosus
by: Lun Hon, Kam, et al.
Published: (2012)

Dermoscopy of discoid lupus erythematosus
by: Jha, Abhijeet K, et al.
Published: (2016)

CONGENITAL LUPUS ERYTHEMATOSUS
by: Bhatt, Taseer Ahmed, et al.
Published: (2011)

Neuropsychiatric Systemic Lupus Erythematosus
by: Popescu, Alexandra, et al.
Published: (2011)

Complement and systemic lupus erythematosus
by: Walport, Mark J
Published: (2002)

Systemic lupus erythematosus
by: Manson, Jessica J, et al.
Published: (2006)

Cytokines in Systemic Lupus Erythematosus
by: Poole, Brian D., et al.
Published: (2010)

Systemic Lupus Erythematosus
by: Okamoto, Hiroshi, et al.
Published: (2012)